{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:21:14Z","timestamp":1788016874162,"version":"build-2784847793"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Gachon University Gil Hospital"},{"name":"Intramural Research Program"},{"DOI":"10.13039\/100000064","name":"National Center for Complementary and Alternative Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000064","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.atherosclerosis.2010.10.036","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T08:12:52Z","timestamp":1288771972000},"page":"1-8","source":"Crossref","is-referenced-by-count":107,"title":["Differential metabolic effects of distinct statins"],"prefix":"10.1016","volume":"215","author":[{"given":"Kwang Kon","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0005","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.102.16.1893","article-title":"Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MOL.0b013e328012b627","article-title":"Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction","volume":"18","author":"Han","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin","volume":"28","author":"Muniyappa","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0020","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0025","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0008-6363(00)00146-2","article-title":"Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability","volume":"47","author":"Koh","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0035","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5551\/jat.13.123","article-title":"Statins: beneficial or adverse for glucose metabolism","volume":"13","author":"Sasaki","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.bjp.0702397","article-title":"Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells","volume":"126","author":"Yada","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0055","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1248\/bpb.26.1681","article-title":"Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin","volume":"26","author":"Kanda","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-5793(01)03007-1","article-title":"Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes","volume":"507","author":"Chamberlain","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0065","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00125-006-0269-5","article-title":"Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycemic control","volume":"49","author":"Nakata","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2005.05.009","article-title":"Atorvastatin induces insulin sensitization in Zucker lean and fatty rats","volume":"184","author":"Wong","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00005344-199907000-00016","article-title":"Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity","volume":"34","author":"Tesfamariam","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5551\/jat.13.329","article-title":"Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells","volume":"13","author":"Ishikawa","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2007.02.013","article-title":"Effect of pravastatin on the development of diabetes and adiponectin production","volume":"196","author":"Takagi","year":"2008","journal-title":"Atherosclerosis"},{"issue":"5A","key":"10.1016\/j.atherosclerosis.2010.10.036_bib0090","doi-asserted-by":"crossref","first-page":"28B","DOI":"10.1016\/S0002-9149(01)01454-0","article-title":"Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"87","author":"McTaggart","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0168-8227(94)90018-3","article-title":"Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures","volume":"23","author":"Farrer","year":"1994","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0026-0495(95)90267-8","article-title":"A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia","volume":"44","author":"Ohrvall","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-9150(99)00352-4","article-title":"Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients","volume":"150","author":"Paolisso","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1081\/ERC-120025034","article-title":"No effect of simvastatin treatment on insulin sensitivity in patients with primary hypercholesterolemia","volume":"29","author":"Altunba\u015f","year":"2003","journal-title":"Endocr Res"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0115","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.amjcard.2007.06.028","article-title":"Simvastatin (40mg\/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome","volume":"100","author":"Devaraj","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.287.5.598","article-title":"Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial","volume":"287","author":"Jula","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0125","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1161\/01.CIR.0000143085.86697.13","article-title":"Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients","volume":"110","author":"Koh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.HYP.0000166722.91714.ba","article-title":"Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes","volume":"45","author":"Koh","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2006.08.061","article-title":"Adiponectin and cardiovascular disease: response to therapeutic interventions","volume":"49","author":"Han","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pcad.2009.06.004","article-title":"Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies","volume":"52","author":"Han","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0145","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2337\/diacare.28.6.1419","article-title":"Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia","volume":"28","author":"Koh","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2005.07.040","article-title":"Anti-inflammatory and metabolic effects of candesartan in hypertensive patients","volume":"108","author":"Koh","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0155","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/dc06-2267","article-title":"Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in non-diabetic patients with hypertension","volume":"30","author":"Koh","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0160","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0165","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2337\/diabetes.54.7.1914","article-title":"Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model","volume":"54","author":"Chen","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0170","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","article-title":"Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0175","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2337\/dc07-2199","article-title":"Simvastatin improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients","volume":"31","author":"Koh","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.metabol.2006.11.007","article-title":"Effect of simvastatin and\/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk\u2014the PIOSTAT Study","volume":"56","author":"Forst","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2008.09.021","article-title":"Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients","volume":"204","author":"Koh","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0190","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/diabetes.52.3.803","article-title":"Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome","volume":"52","author":"Watts","year":"2003","journal-title":"Diabetes"},{"issue":"6 Pt 1","key":"10.1016\/j.atherosclerosis.2010.10.036_bib0195","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/clinchem\/48.6.877","article-title":"Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity","volume":"48","author":"Chan","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0200","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/eurheartj\/ehi482","article-title":"A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study","volume":"26","author":"Stalenhoef","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0205","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1464-5491.2003.00993.x","article-title":"Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose","volume":"20","author":"Costa","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0210","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2006.01.055","article-title":"Effect of atorvastatin (10mg\/day) on glucose metabolism in patients with the metabolic syndrome","volume":"98","author":"Huptas","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2006.08.028","article-title":"Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia","volume":"193","author":"Nakamura","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2265.2008.03412.x","article-title":"Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes","volume":"71","author":"von Eynatten","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0225","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2005.02.052","article-title":"Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of patients with combined hyperlipidemia","volume":"45","author":"Koh","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0230","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0240","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00125-005-1858-4","article-title":"The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis","volume":"48","author":"Gerstein","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0245","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0250","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2362.2005.01549.x","article-title":"Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia","volume":"35","author":"ter Avest","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0255","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.HYP.28.4.647","article-title":"Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects","volume":"28","author":"Chan","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0260","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.biopha.2004.09.005","article-title":"Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome","volume":"58","author":"Guclu","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0265","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.atherosclerosis.2006.08.023","article-title":"Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease","volume":"194","author":"Sugiyama","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0270","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.metabol.2005.02.011","article-title":"Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients","volume":"54","author":"Gannage-Yared","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00041552-200403000-00010","article-title":"Leptin, obesity and cardiovascular disease","volume":"13","author":"Correia","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0280","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1161\/CIRCULATIONAHA.107.741645","article-title":"Leptin and cardiovascular disease: response to therapeutic interventions","volume":"117","author":"Koh","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2169\/internalmedicine.45.1476","article-title":"Effect of pravastatin and atorvastatin on glucose metabolism in nondiabetic patients with hypercholesterolemia","volume":"45","author":"Ishikawa","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0290","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1507\/endocrj.K06-198","article-title":"Preferable effect of pravastatin compared to atorvastatin on beta cell function in Japanese early-state type 2 diabetes with hypercholesterolemia","volume":"54","author":"Mita","year":"2007","journal-title":"Endocr J"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0295","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1440-1681.2008.04945.x","article-title":"Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients","volume":"35","author":"Ando","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0300","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.diabres.2009.10.008","article-title":"Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis","volume":"87","author":"Baker","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0310","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"issue":"Supplement III-834","key":"10.1016\/j.atherosclerosis.2010.10.036_bib0315","article-title":"High-dose atorvastatin associated with worse glycemic control: a PROVE-IT TIMI 22 substudy","volume":"110","author":"Sabatine","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0320","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2337\/dc05-2465","article-title":"Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes. The treating to new targets (TNT) study","volume":"29","author":"Shepherd","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0325","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0330","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0335","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diacare.26.10.2713","article-title":"Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial","volume":"26","author":"Keech","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0340","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2004.02142.x","article-title":"Statins and newly diagnosed diabetes","volume":"58","author":"Jick","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0345","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/dc09-0738","article-title":"Statin therapy and risk of developing type 2 diabetes: a meta-analysis","volume":"32","author":"Rajpathak","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0350","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1185\/030079908X292029","article-title":"The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"24","author":"Coleman","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0355","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0360","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0365","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.10.036_bib0370","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(10)60973-7","article-title":"More insights on the dysglycaemia\u2013cardiovascular connection","volume":"375","author":"Gerstein","year":"2010","journal-title":"Lancet"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010008907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010008907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T13:30:22Z","timestamp":1592055022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010008907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0021915010008907"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.10.036","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}